Compare XNPT to:
Real-Time: 16.02 0.07 (0.44%) 10:00am ET
| Last Trade: | 15.86 |
|---|---|
| Trade Time: | 9:46am ET |
| Change: | |
| Prev Close: | 15.95 |
| Open: | 16.11 |
| Bid: | 15.83 x 100 |
| Ask: | 15.88 x 500 |
| 1y Target Est: | 32.23 |
| Day's Range: | 15.81 - 16.14 |
|---|---|
| 52wk Range: | 13.36 - 29.52 |
| Volume: | 7,260 |
| Avg Vol (3m): | 367,503 |
| Market Cap: | 481.19M |
| P/E (ttm): | N/A |
| EPS (ttm): | -2.43 |
| Div & Yield: | N/A (N/A) |
| Thu, Nov 19 | XENOPORT INC Files SEC form 8-K, Other EventsEDGAR Online |
| Thu, Nov 19 | Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs SyndromeBusiness Wire |
| Mon, Nov 16 | Music to Health-Care Investors' Earsat Motley Fool |
| Fri, Nov 13 | FDA Delays Cadence Drug Review: BioBuzzat TheStreet.com |
| Wed, Nov 11 | Correction: XenoPort-Glaxo drugAP |
| Tue, Nov 10 | Glaxo, XenoPort drug to get longer FDA reviewAP |
| Tue, Nov 10 | CORRECTING and REPLACING GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010Business Wire |
| Tue, Nov 10 | 3 Companies Looking for Gratitude Earlyat Motley Fool |
| Mon, Nov 9 | Doc Offers Top Hep C Drug Picks: BioBuzzat TheStreet.com |
| Mon, Nov 9 | XENOPORT INC Files SEC form 8-K, Other EventsEDGAR Online |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.